| Lankester F, Russell GC, Lugelo A, Ndabigaye A, Mnyambwa N, Keyyu J, Kazwala R, GrantD, Percival A, Deane D, Haig DM and Cleaveland S. 2016. A field vaccine trial in Tanzaniademonstrates partial protection against malignant catarrhal fever in cattle. Vaccine, 34,831-8. |
| Lankester F, Lugelo A, Werling D, Mnyambwa N, Keyyu J, Kazwala R, Grant D, Smith S,Parameswaran N, Cleaveland S, Russell G and Haig DM. 2016. The efficacy of alcelaphineherpesvirus-1 (AlHV-1) immunization with the adjuvants Emulsigen(R) and the monomericTLR5 ligand FliC in zebu cattle against AlHV-1 malignant catarrhal fever induced byexperimental virus challenge. Vet Microbiol, 195, 144-153. |
| Parameswaran N, Dewals BG, Giles TC, Deppmann C, Blythe M, Vanderplasschen A, Emes RD and Haig DM. 2014. The A2 gene of alcelaphine herpesvirus-1 is atranscriptionalregulator affecting cytotoxicity in virus-infected T cells but is not required for malignantcatarrhal fever induction in rabbits. Virus Res, 188, 68-80. |
| Parameswaran N, Russell GC, Bartley K, Grant DM, Deane D, Todd H, Dagleish MP and Haig DM. 2014. The effect of the TLR9 ligand CpG-oligodeoxynucleotide on the protectiveimmune response to alcelaphine herpesvirus-1-mediated malignant catarrhal fever in cattle.Vet Res, 45, 59. |
| Russell GC, Benavides J, Grant DM, Todd H, Thomson J, Puri V, Nath M and Haig DM. 2012. Host gene expression changes in cattle infected with Alcelaphine herpesvirus 1. Virus Res, 169, 246-54. |